Neoantigen-reactive [CD8.sup.+] T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma

Neoantigen-reactive [CD8.sup.+] T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma

FUNDING. NEYE Foundation; European Research Council; Lundbeck Foundation Fellowship; Carlsberg Foundation.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of clinical investigation 2022-01, Vol.132 (2)
Hauptverfasser: Kristensen, Nikolaj Pagh, Heeke, Christina, Tvingsholm, Siri A, Borch, Annie, Draghi, Arianna, Crowther, Michael D, Carri, Ibel, Munk, Kamilla K, Holm, Jeppe Sejero, Bjerregaard, Anne-Mette, Bentzen, Amalie Kai, Marquard, Andrea M, Szallasi, Zoltan, McGranahan, Nicholas, Andersen, Rikke, Nielsen, Morten, Jonsson, Goran B, Donia, Marco, Svane, Inge Marie, Hadrup, Sine Reker
Format: Artikel
Sprache:eng
Schlagworte:
Care and treatment
CD8 lymphocytes
Cellular therapy
Health aspects
Melanoma
Patient outcomes
Tumor antigens
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:FUNDING. NEYE Foundation; European Research Council; Lundbeck Foundation Fellowship; Carlsberg Foundation.
ISSN:0021-9738
DOI:10.1172/JCI150535